(Correction) Notice Regarding Correction of ‘Announcement on the Commencement of Tender Offer by TCG2509 Co., Ltd. for Common Shares of Hogi Medical Co., Ltd. (Securities Code: 3593)’

Overview of Tender Offer and Corrections

TCG2509 Co., Ltd. commenced a tender offer for common shares of Hogi Medical Co., Ltd. on December 18, 2025. The tender offerors initially recognized that the number of shares held by Gransham, Mayo, and Van Otterloo & Company LLC (GMO) was 2,237,900 shares (10.38%). However, on December 26, 2025, it was revealed that the actual number was 2,256,100 shares (10.46%), which is 18,200 shares more. Accordingly, on January 6, 2026, an amendment to the subscription agreement with GMO was executed, and the descriptions in the tender offer notification and public announcement of the tender offer commencement were corrected.

Impact on Shareholders and Future Outlook

The lower limit of the scheduled purchase quantity is set at 14,362,400 shares (66.62%), and if the total number of tendered shares does not reach this threshold, the purchase will not proceed. Even after the correction of the number of shares owned by GMO, the lower limit of the scheduled purchase quantity approximately maintains the level of a majority of minority shareholders. The tender offerors judge that the amendment to the subscription agreement with GMO does not impair the rationality, fairness, or appropriateness of this transaction. Going forward, this tender offer will continue to be properly conducted in accordance with Japan’s Financial Instruments and Exchange Act.